Logo
  • ABOUT US
  • PIPELINE & PUBLICATIONS
  • Investor Overview
  • NEWS
Menu Trigger
  • ABOUT US
  • PIPELINE & PUBLICATIONS
  • Investor Overview
  • NEWS
  • Corporate Governance
  • Careers
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Mar 12, 2021 6:41am EST

Alzamend Neuro®, Inc. announces an agreement to sell $10,000,000 of its securities to Digital Power Lending LLC, a subsidiary of Ault Global Holdings, Inc.

Dec 29, 2020 5:44pm EST

Alzamend Neuro®, Inc. Announces Confidential Submission of Draft Registration Statement Relating to the Proposed Initial Public Offering of Its Common Stock

Nov 16, 2020 9:00am EST

Alzamend Neuro®, Inc. Registration is Closing to Join the Shareholder and Investor Conference Call and Webcast Set for Tomorrow, November 17, 2020 to Provide Update and Plans for 2021

Nov 03, 2020 9:45am EST

Alzamend Neuro®, Inc. Announces Shareholder and Investor Conference Call and Webcast to Provide Update and Plans for 2021

Oct 27, 2020 6:56am EDT

New Immunomodulatory Therapeutic Vaccine that Targets Oligomeric Amyloid-β Could be Step Towards Halting Alzheimer’s Disease Progression

Oct 27, 2020 6:30am EDT

DPW Holdings’ Announces that the Journal of Alzheimer’s Disease Highlights Milestone Research (AL002) Licensed by Alzamend Neuro® from the University of South Florida

Jul 16, 2019 2:43pm EDT

Alzamend Neuro™ Announces Appointment of Dr. Eric McDade to Its Scientific Advisory Board

Jul 12, 2019 4:10pm EDT

Alzamend Neuro™ Announces Senior Management to Participate in the 2019 Alzheimer’s Association International Conference®

Jul 09, 2019 8:00am EDT

Alzamend Neuro™ Announces First Appointment to Scientific Advisory Board

Dec 26, 2018 9:00am EST

Alzamend Neuro™ Completes New Management Team for 2019

  • arrow_back
  • 1
  • 2
  • 3
  • 4
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
Logo
  • Facebook
  • Twitter
  • Alzamend Neuro is a registered mark of Alzamend Neuro Inc.
  • © Copyright 2016 - 2022 | All rights reserved. | Terms of Use